Patents Assigned to Soft Gene GmbH
  • Design principle for the construction of expression constructs for gene therapy
    Publication number: 20030054392
    Abstract: The invention concerns an expressible nucleic acid construct, which contains only the sequence information necessary for expressing a gene for RNA or protein synthesis. Expression constructs of this type can be used in gene therapy and genetic vaccination and avoid many of the risks associated with constructs today. The invention further concerns the possibility of improving the conveying of the construct into cells or tissue by covalent linkage of the construct, for example to particles of peptides.
    Type: Application
    Filed: August 27, 2002
    Publication date: March 20, 2003
    Applicant: SOFT GENE GMBH
    Inventors: Burghardt Wittig, Claas Junghans
  • Design principle for construction of expression constructs for gene therapy
    Patent number: 6451593
    Abstract: The invention concerns an expressible nucleic acid construct, which contains only the sequence information necessary for expressing a gene for RNA or protein synthesis. Expression constructs of this type can be used in gene therapy and genetic vaccination and avoid many of the risks associated with constructs today. The invention further concerns the possibility of improving the conveying of the construct into cells or tissue by covalent linkage of the construct, for example to particles or peptides.
    Type: Grant
    Filed: May 12, 1999
    Date of Patent: September 17, 2002
    Assignee: Soft Gene GmbH
    Inventors: Burghardt Wittig, Claas Junghans